MERCK KGAA/S (OTCMKTS:MKKGY) Earns “Neutral” Rating from JPMorgan Chase & Co.

JPMorgan Chase & Co. restated their neutral rating on shares of MERCK KGAA/S (OTCMKTS:MKKGY) in a research note released on Tuesday, The Fly reports.

Separately, Morgan Stanley reiterated an equal weight rating on shares of MERCK KGAA/S in a research note on Monday.

OTCMKTS MKKGY traded down $0.22 on Tuesday, reaching $28.95. The company had a trading volume of 18,178 shares, compared to its average volume of 101,785. MERCK KGAA/S has a 1 year low of $16.55 and a 1 year high of $29.35. The firm has a 50-day moving average of $27.00 and a 200-day moving average of $23.82.


MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and performance materials sectors worldwide. It offers prescription medicines to treat cancer, multiple sclerosis, infertility, growth deficiencies, type 2 diabetes, cardiovascular and thyroid diseases, as well as squamous cell carcinoma of the head and neck; diagnostics and prescription drugs for allergen immunotherapy; and fertility treatments.

Featured Article: What does a bar chart mean for investors?

The Fly

Receive News & Ratings for MERCK KGAA/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MERCK KGAA/S and related companies with's FREE daily email newsletter.